ImmunityBio
IBRX
$6.42
Share price
-2.87%
Change (1 day)
118.37%
Change (1 year)
Categories
ImmunityBio (IBRX) - Net assets
Net assets on the balance sheet as of March 2024 : -$0.7 B
According to ImmunityBio's latest financial reports the company has -$0.7 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
ImmunityBio - Net assets on balance sheet (from 2020 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-0.45 B | 84.42% |
| 2021-12-31 | $-0.25 B | 105.85% |
| 2020-12-31 | $-0.12 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.32 B | -147.56% | 🇺🇸 USA |